Red X iconGreen tick iconYellow tick icon

Mark RichardsProfessor

BA (Massey) MB ChB (Otago) MD(Otago,) PhD(Otago) DSc (Otago) FRACP FRCP FRSNZ

Department of Medicine
University of Otago, Christchurch
PO Box 4345
Christchurch
New Zealand

Email mark.richards@cdhb.health.nz

Mark Richards is the director of the Christchurch Heart Institute.

He coordinates and directs multi-disciplinary programmes of grant-funded translational cardiovascular research which seek to improve diagnostic, prognostic and therapeutic options in heart disease.

He is pursuing studies of epidemiological, molecular biological, neurohormonal and therapeutic aspects of acute and chronic cardiovascular disorders including hypertension, coronary syndromes, and the full spectrum of heart failure.

Richards holds the Heart Foundation of New Zealand's Chair in Cardiovascular Studies.

He also holds joint appointments at the University of Otago and the National University of Singapore's Cardiovascular Research Institute.
Email mdcarthu@nus.edu.sg (University of Singapore)

Current roles

Research interests

  • Neurohormonal physiology and pathophysiology in cardiovascular health and disease
  • Heart Failure
  • Acute Coronary Syndromes
  • Hypertension
  • Vasoactive Hormones
  • The Cardiac Natriuretic Peptides

Publications

Sim, H. W., Koh, K. W. L., Poh, S.-C., Chan, S. P., Marchesseau, S., Singh, D., … Richards, A. M., & Chan, M. Y. (2024). Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: A secondary analysis of the randomized controlled IMMACULATE trial. Journal of Thrombosis & Thrombolysis. Advance online publication. doi: 10.1007/s11239-023-02931-6

Azzo, J. D., Dib, M.-J., Zagkos, L., Zhao, L., Wang, Z., Chang, C.-P., … Richards, A. M., … Chirinos, J. A. (2024). Proteomic associations of NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide) in heart failure with preserved ejection fraction. Circulation: Heart Failure, 17(2), e011146. doi: 10.1161/circheartfailure.123.011146

van Essen, B. J., Tharshana, G. N., Ouwerkerk, W., Yeo, P. S. D., Sim, D., Jaufeerally, F., … Richards, A. M. (2024). Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach. European Journal of Heart Failure. Advance online publication. doi: 10.1002/ejhf.3156

Ling, S. S. M., Lilyanna, S., Ng, J. Y. X., Chong, J. P. C., Lin, Q., Yong, X. E., … Richards, A. M., & Liew, O. W. (2024). Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies. Cellular & Molecular Life Sciences, 81, 42. doi: 10.1007/s00018-023-05083-1

Salman, O., Zhao, L., Cohen, J. B., Dib, M. J., Azzo, J. D., Gan, S., Richards, A. M., … Chirinos, J. (2024). Proteomic correlates and prognostic significance of kidney injury in heart failure with preserved ejection fraction. Journal of Cardiac Failure, 30(1), (pp. 213-214). doi: 10.1016/j.cardfail.2023.10.235